School Of Medicine 7
301. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
302. Advancing Gait Rehabilitation: A Systematic Review of Robotic Exoskeletons for Cerebral Palsy
303. The Roles of Endogenous D2R Dopamine and μ-opioid Receptors of the Brain in Alcohol use Disorder
304. Self-reported changes in alcohol and tobacco use during COVID-19: Findings from the eastern part of WHO European Region
305. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
306. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
307. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
308. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
309. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
310. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
311. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
312. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
313. Gas Chromatography–Mass Spectrometry Profiling of Volatile Metabolites Produced by Some Bacillus spp. and Evaluation of Their Antibacterial and Antibiotic Activities
314. Molecular Characterization of Some Bacillus Species from Vegetables and Evaluation of Their Antimicrobial and Antibiotic Potency
315. Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry
316. Optimization of Cladding Diameter for Refractive Index Sensing in Tilted Fiber Bragg Gratings
317. The Implementation of Antimicrobial Consumption Surveillance and Stewardship in Human Healthcare in Post-Soviet States: A Systematic Review
318. Digestive system and severe acute respiratory syndrome coronavirus 2: New era of microbiome study and gastrointestinal tract manifestations during the coronavirus disease-19 pandemic
319. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE v survey in 16 European countries
320. Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimers Disease
321. Osteoporosis: Relevance of Biomolecules for Diagnosis and Treatment
322. The Influence of Vitamin D on Pregnancy and Outcomes: Current Knowledge and Future Perspectives
323. Associations between serum levels of brain-derived neurotrophic factor, corticotropin releasing hormone and mental distress in vitiligo patients
324. Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients
325. Impact of Social Determinants of Health on the Incidence of Tuberculosis in Central Asia
326. Trends of ciprofloxacin use in Kazakhstan, impacts of COVID-19, and strategies for AMR control
327. Trends of ciprofloxacin use in Kazakhstan, impacts of COVID-19, and strategies for AMR control
328. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
329. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
330. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
331. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
332. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
333. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
334. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
335. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
336. Actovegin in the management of patients after ischemic stroke: A systematic review
337. Menstrual cycle changes after COVID-19 vaccination or infection: Not two sides of the same coin
338. A global action agenda for turning the tide on fatty liver disease
339. A global action agenda for turning the tide on fatty liver disease
340. A global action agenda for turning the tide on fatty liver disease
341. A global action agenda for turning the tide on fatty liver disease
342. A global action agenda for turning the tide on fatty liver disease
343. Advancing the global public health agenda for NAFLD: a consensus statement
344. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
345. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
346. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
347. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
348. Deep Learning Methods for Interpretation of Pulmonary CT and X-ray Images in Patients with COVID-19-Related Lung Involvement: A Systematic Review
349. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
350. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
1 5 6 7 8 9 15